Lori L. Huston

Lori L. Huston serves as an Acquisition Administrator at the Naval Health Research Center (N63116), where she plays a pivotal role in executing mission-critical procurements that support the health and operational readiness of Navy and Marine Corps personnel. Her responsibilities encompass the full lifecycle of acquisition activities for advanced biomedical technologies, including diagnostic systems, wearable biosensors, and laboratory instrumentation. She ensures compliance with federal acquisition regulations while aligning procurement strategies with the Center’s focus on rapid pathogen detection, physiological monitoring, and field-deployable medical innovations. Huston’s portfolio is highly technical, emphasizing solutions that bridge laboratory research with operational field environments. While specific contractor names are not available, Huston routinely engages with specialized manufacturers and scientific service providers capable of delivering high-precision medical devices and analytical systems. Her working relationships are characterized by collaboration with vendors possessing robust quality management systems, validated manufacturing processes, and expertise in regulatory compliance for medical and diagnostic products. She fosters partnerships with firms experienced in FDA-regulated environments and those capable of rapid prototyping and scalable production of novel health technologies. Huston’s contracting patterns reflect a strong preference for open competition, with 86.9% of acquisitions conducted without set-asides. However, she actively supports small business participation, with 8.2% of awards designated as total small business set-asides and 4.9% awarded through 8(a) competed contracts. Her approach balances mission urgency with socioeconomic goals, ensuring that qualified small businesses have meaningful access to high-impact procurement opportunities. Her primary procurement focus lies in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), reflecting deep expertise in diagnostic reagents and lab-based pathogen detection systems. She also frequently procures analytical laboratory instruments (NAICS 334516) and specialized technical consulting services (NAICS 541690), demonstrating a command of biomedical engineering, diagnostic innovation, and applied research support services critical to naval health operations.